23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function.

Authors:
Fenaux J; Fang X; Huang YM; Melero C; Bonnans C and 12 more

Journal:
Oncoimmunology

Publication Year: 2023

DOI:
10.1080/2162402X.2023.2217737

PMCID:
PMC10243377

PMID:
37288324

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Oncoimmunology

Abbreviation: Oncoimmunology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor ac…
Albu DI; Wolf BJ; Qin Y and 12 more (2024) - Transparency Score: 2/6
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherap…
Ying L; Hu Z; Lu Y and 11 more (2024) - Transparency Score: 2/6
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Glöckner HJ; Martinenaite E; Landkildehus Lisle T and 5 more (2024) - Transparency Score: 3/6
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8<sup>+</sup>T cell func…
Wei W; Tian L; Zheng X and 6 more (2024) - Transparency Score: 3/6
Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor …
Ramil CP; Xiang H; Zhang P and 10 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability statement the data that support the findings of this study are available upon reasonable request. supplementary material supplemental data for this article can be accessed online at https://doi"

Code Sharing
Evidence found in paper:

"Disclosure statement XF, YH, CM, ELL, TP, AZ, MP, SRM, DG, MS, CCL: Employees of 23andMe JF, CB, CL, ZY, WC, AC: Employees of 23andMe at the time this work was performed"

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025